Twyman-Saint Victor et al. then used a corresponding melanoma mouse model and found that low CD8+/Treg ratio predicted resistance of melanoma to anti-CTLA4 therapy and radiation, and profiling of these tumors revealed high levels of tumor PD-L1. This evidence concerns the gene CD8A and neoplasm.